ENTITY

TuHURA Biosciences (HURA US)

11
Analysis
Health Care • United States
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company. The Company focuses on developing technologies to overcome resistance to cancer immunotherapy. TuHURA Biosciences operates in the United States.
more
Company Event • 14 Nov 2026 01:30 • Upcoming
Add To Calendar

Q3 2026

Company Event • 15 Sep 2026 04:00 • Upcoming
Add To Calendar

H.C. Wainwright 28th Annual Global Investment Conference

Company Event • 18 Aug 2026 21:00 • Latest

AGM 2026

Company Event • 14 Aug 2026 19:30 • Upcoming
Add To Calendar

Q2 2026

Company Event • 13 Aug 2026 00:30

Canaccord Genuity's 46th Annual Growth Conference

x